irinotecan has been researched along with Sarcoma, Kaposi in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| di Gennaro, G; Schioppa, O; Simonelli, C; Tirelli, U; Vaccher, E | 1 |
| Cattarossi, G; Corona, G; Sartor, I; Toffoli, G; Vaccher, E | 1 |
| Corona, G; Innocenti, F; Sandron, S; Sartor, I; Tirelli, U; Toffoli, G; Vaccher, E | 1 |
1 trial(s) available for irinotecan and Sarcoma, Kaposi
| Article | Year |
|---|---|
Evidence of activity of Irinotecan in patients with advanced AIDS-related Kaposi's sarcoma.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antiretroviral Therapy, Highly Active; Camptothecin; Hematologic Diseases; HIV Infections; Humans; Irinotecan; Male; Middle Aged; Sarcoma, Kaposi; Treatment Outcome | 2005 |
2 other study(ies) available for irinotecan and Sarcoma, Kaposi
| Article | Year |
|---|---|
Potential hazard of pharmacokinetic interactions between lopinavir-ritonavir protease inhibitors and irinotecan.
Topics: Administration, Oral; Adult; Antineoplastic Agents, Phytogenic; Antiretroviral Therapy, Highly Active; Camptothecin; Drug Interactions; HIV Infections; HIV Protease Inhibitors; Humans; Irinotecan; Lopinavir; Male; Pyrimidinones; Ritonavir; Sarcoma, Kaposi | 2005 |
Lopinavir-ritonavir dramatically affects the pharmacokinetics of irinotecan in HIV patients with Kaposi's sarcoma.
Topics: Adenine; Adult; Aged; Anti-HIV Agents; Antineoplastic Agents, Phytogenic; Antiretroviral Therapy, Highly Active; Area Under Curve; Camptothecin; Drug Therapy, Combination; HIV Infections; Humans; Irinotecan; Lamivudine; Lopinavir; Male; Middle Aged; Organophosphonates; Pyrimidinones; Ritonavir; Sarcoma, Kaposi; Tenofovir; White People | 2008 |